The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
September 18th 2024
The FDA has approved the Eversense 365, the world’s first 1-year continuous glucose monitor, with US availability expected in late 2024.
September 7th 2024
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Heart Disease Linked to Cognitive Decline in Elderly Postmenopaual Women
A recent study published online in the Journal of the American Heart Association discovered an association between cardiovascular disease (CVD) and cognitive decline in postmenopausal women between the ages of 65 and 79 years old.
Dramatic Weight Loss from Bariatric Surgery Can Alter Identity
January 7th 2014While numerous patients require psychiatric interventions before and immediately after surgery, a new report addresses a different psychological process that can occur months or even years later: major quality-of-life (QOL) perception changes related to dramatic weight loss.
New Management and Treatment Guidelines Published for Hepatitis C Virus
The European Association for the Study of the Liver published their updated Clinical Practice Guidelines for the management of the hepatitis C virus, which includes updates regarding people who inject recreational drugs.
Environmental, Familial, Neurohormonal Factors May Explain Obesity Epidemic
December 6th 2013A mini-symposium called "Food for Thought" explored multiple factors associated with obesity, including the environment's role in obesity development, sedentary lifestyles and metabolic dysregulation, and the bidirectional relationship between the brain and peripheral signals and responses.
FDA Reduces Restrictions on Diabetes Medication Rosiglitazone
November 26th 2013Following an extended review of safety data that showed no elevated risk of heart attack or death in patients taking rosiglitazone, the FDA announced it is lifting certain restrictions on the prescribing and dispensing of the drug.
Patients with Atrial Fibrillation Are at High Risk of Medication Noncompliance
November 18th 2013Study results presented at AHA 2013 show that nearly half of patients with nonvalvular atrial fibrillation (NVAF) are at high risk of discontinuing their medications. However, patients taking novel anticoagulants such as dabigatran or rivaroxaban were less likely to stop their medications.
The Changing Face of Bipolar Care: Initial Results of the MedRisk Study
November 16th 2013Study looks at an integrated care model for treating bipolar depression that incorporates a multidisciplinary care team, individualized lifestyle interventions, focused patient education, weight loss and nutrition counseling, and efforts to promote treatment adherence.
Risk Indices in Perioperative Medicine: What Do They Tell Us?
Presentation at the 2013 Southern Hospital Medicine Conference reviewed the clinical application of several key risk indices, including the Revised Cardiac Risk Index and the Vascular Study Group of New England Risk Index.